NCT00670592 2020-12-17
Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
Novartis
Phase 1/2 Completed
Clinical Trials
4 trialsNCT01275209 2020-12-08
LIFT
Novartis
Phase 1 Completed
NCT00231166 2018-10-11
Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
Novartis
Phase 1 Completed
NCT00108108 2012-10-01
Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy
Novartis
Phase 1 Terminated